UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 129

Sortiert nach

Does combination of “cold” and “hot” somatostatin analogs prolong survival of patients with neuroendocrine neoplasms?

Endocrine Journal, 2017, Vol.64(2), pp.171-177

2017

Volltextzugriff (PDF)

Does combination of "cold" and "hot" somatostatin analogs prolong survival of patients with neuroendocrine neoplasms?

ENDOCRINE JOURNAL, 2017-02, Vol.64 (2), p.171-177

2017

Volltextzugriff (PDF)

Liquid levothyroxine in the treatment of myxoedema coma

Endokrynologia Polska, 2023-01, Vol.74 (2), p.215-216

2023

Volltextzugriff (PDF)

Glucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC-99mTc/EDDA)NH2]-exendin-4 for the detection of insulinoma

European journal of nuclear medicine and molecular imaging, 2013-04, Vol.40 (4), p.524-531

2013

Volltextzugriff (PDF)

Peptide receptor radionuclide therapy as a potential tool for neoadjuvant therapy in patients with inoperable neuroendocrine tumours (NETs)

European journal of nuclear medicine and molecular imaging, 2011-09, Vol.38 (9), p.1669-1674

2011

Volltextzugriff (PDF)

Clinical challenges and dilemmas in the management of advanced pancreatic neuroendocrine tumour - the first manifestation of von Hippel-Lindau disease in a young patient

Endokrynologia Polska, 2021-01, Vol.72 (4), p.412-413

2021

Volltextzugriff (PDF)

Prevalence of Selected Single-Nucleotide Variants in Patients with Neuroendocrine Tumors—Potential Clinical Relevance

Journal of clinical medicine, 2022-09, Vol.11 (19), p.5536

2022

Volltextzugriff (PDF)

99mTc Labeled Glucagon-Like Peptide-1-Analogue (99mTc-GLP1) Scintigraphy in the Management of Patients with Occult Insulinoma

PloS one, 2016-08, Vol.11 (8), p.e0160714-e0160714

2016

Volltextzugriff (PDF)

Gastroenteropancreatic neuroendocrine neoplasms: a 10-year experience of a single center

Polskie archiwum medycyny wewne̦trznej, 2015-01, Vol.125 (5), p.337-346

2015

Volltextzugriff (PDF)

NEN - the role of somatostatin receptor scintigraphy in clinical setting

Nuclear medicine review. Central & Eastern Europe, 2016-01, Vol.19 (2), p.118-125

2016

Volltextzugriff (PDF)

Epidemiology of gastroenteropancreatic neuroendocrine neoplasms in Krakow and Krakow district in 2007-2011

Endokrynologia Polska, 2017-01, Vol.68 (1), p.42

2017

Volltextzugriff (PDF)

Efficacy of multimodal anticancer therapy in the course of pancreatic neuroendocrine carcinoma

Endokrynologia Polska, 2021-01, Vol.72 (2), p.183-184

2021

Volltextzugriff (PDF)

sup.99mTc Labeled Glucagon-Like Peptide-1-Analogue (.sup.99mTc-GLP1) Scintigraphy in the Management of Patients with Occult Insulinoma

PloS one, 2016-08, Vol.11 (8), p.e0160714

2016

Volltextzugriff (PDF)

Are RECIST criteria sufficient to assess response to therapy in neuroendocrine tumors?

Clinical imaging, 2012-07, Vol.36 (4), p.360-364

2012

Volltextzugriff (PDF)

Case report of a patient with initially inoperable well-differentiated midgut neuroendocrine tumor (WDNT)--PRRT and long-acting somatostatin analogs as the neoadjuvant therapy

Nuclear medicine review. Central & Eastern Europe, 2012-01, Vol.15 (2), p.137-139

2012

Volltextzugriff (PDF)

Can treatment using radiolabelled somatostatin analogue increase the survival rate in patients with non-functioning neuroendocrine pancreatic tumours?

Nuclear medicine review. Central & Eastern Europe, 2011-01, Vol.14 (2), p.73-78

2011

Volltextzugriff (PDF)

P10-5-6 Side-effects and response to the radioisotope 90Y/177Lu DOTA-TATE therapy in patients with disseminated NET-Do repeated cycles of PRRT increase toxicity of the therapy?

ENDOCRINE JOURNAL, 2010, Vol.57 (suppl.2-2), p.S587-S587

2010

Volltextzugriff (PDF)

P3-1-8 Assessment of somatostatin receptor expression in predicting results of PRRT(peptide receptor radionuclide therapy)in disseminated neuroendocrine tumours(NET)

ENDOCRINE JOURNAL, 2010, Vol.57 (suppl.2-2), p.S443-S443

2010

Volltextzugriff (PDF)

O15-2 Case report of a patient with two independent well-differentiated midgut neuroendocrine tumors(WDNT)-diagnostic doubts and treatment options

ENDOCRINE JOURNAL, 2010, Vol.57 (suppl.2-1), p.S348-S348

2010

Volltextzugriff (PDF)

Efficacy and safety of ⁹⁰Y-DOTATATE therapy in neuroendocrine tumours

Endokrynologia polska, 2011-01, Vol.62 (5), p.392-400

2011

Volltextzugriff (PDF)

Efficacy and safety of 90Y-DOTATATE therapy in neuroendocrine tumours

Endokrynologia Polska, 2011, Vol.62 (5), p.392

2011

Volltextzugriff (PDF)

Epidemiologia nowotworów neuroendokrynnych układu pokarmowego w Krakowie i powiecie krakowskim w latach 2007-2011

Endokrynologia polska, 2017-03, Vol.68 (1), p.42-46

2017

Volltextzugriff (PDF)

MON-584 Iodine Nutrition Status in Pregnancy: Is the Situation in Poland Improving?

Journal of the Endocrine Society, 2019-04, Vol.3 (Supplement_1)

2019

Volltextzugriff (PDF)

Repeated cycles of peptide receptor radionuclide therapy (PRRT) – Results and side-effects of the radioisotope 90Y-DOTA TATE, 177Lu-DOTA TATE or 90Y/177Lu-DOTA TATE therapy in patients with disseminated NET

Radiotherapy and oncology, 2012-01, Vol.102 (1), p.45-50

2012

Volltextzugriff (PDF)

Repeated cycles of peptide receptor radionuclide therapy (PRRT) – Results and side-effects of the radioisotope90 Y-DOTA TATE,177 Lu-DOTA TATE or90 Y/177 Lu-DOTA TATE therapy in patients with disseminated NET

Radiotherapy and oncology, 2011, Vol.102 (1), p.45-50

2011

Volltextzugriff (PDF)

1 – 25 von 129

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SeriePsychiatria Polska

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(118)
Mit Volltextzugriff
(116)

Publikationsform

Artikel
(121)
Buchkapitel
(8)

Sprache

Englisch
(118)
Japanisch
(11)
Polnisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(71)
Life Sciences & Biomedicine
(61)
Humans
(52)
Female
(31)
Male
(24)
Middle Aged
(21)
Adult
(18)
Aged
(18)
Chemistry
(16)
Physical Sciences
(16)
Animals
(11)
Adolescent
(9)
Neuroendocrine Tumors
(9)
Patients
(9)
Biochemistry & Molecular Biology
(8)
Endocrinology & Metabolism
(8)
Environmental Sciences
(8)
Environmental Sciences & Ecology
(8)
Peptide Receptor Radionuclide Therapy
(8)
Poland
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Does combination of “cold” and “hot” somatostatin analogs prolong survival of patients with neuroendocrine neoplasms?

Does combination of "cold" and "hot" somatostatin analogs prolong survival of patients with neuroendocrine neoplasms?

Liquid levothyroxine in the treatment of myxoedema coma

Glucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC-99mTc/EDDA)NH2]-exendin-4 for the detection of insulinoma

Peptide receptor radionuclide therapy as a potential tool for neoadjuvant therapy in patients with inoperable neuroendocrine tumours (NETs)

Clinical challenges and dilemmas in the management of advanced pancreatic neuroendocrine tumour - the first manifestation of von Hippel-Lindau disease in a young patient

Prevalence of Selected Single-Nucleotide Variants in Patients with Neuroendocrine Tumors—Potential Clinical Relevance

99mTc Labeled Glucagon-Like Peptide-1-Analogue (99mTc-GLP1) Scintigraphy in the Management of Patients with Occult Insulinoma

Gastroenteropancreatic neuroendocrine neoplasms: a 10-year experience of a single center

NEN - the role of somatostatin receptor scintigraphy in clinical setting

Epidemiology of gastroenteropancreatic neuroendocrine neoplasms in Krakow and Krakow district in 2007-2011

Efficacy of multimodal anticancer therapy in the course of pancreatic neuroendocrine carcinoma

sup.99mTc Labeled Glucagon-Like Peptide-1-Analogue (.sup.99mTc-GLP1) Scintigraphy in the Management of Patients with Occult Insulinoma

Are RECIST criteria sufficient to assess response to therapy in neuroendocrine tumors?

Case report of a patient with initially inoperable well-differentiated midgut neuroendocrine tumor (WDNT)--PRRT and long-acting somatostatin analogs as the neoadjuvant therapy

Can treatment using radiolabelled somatostatin analogue increase the survival rate in patients with non-functioning neuroendocrine pancreatic tumours?

P10-5-6 Side-effects and response to the radioisotope 90Y/177Lu DOTA-TATE therapy in patients with disseminated NET-Do repeated cycles of PRRT increase toxicity of the therapy?

P3-1-8 Assessment of somatostatin receptor expression in predicting results of PRRT(peptide receptor radionuclide therapy)in disseminated neuroendocrine tumours(NET)

O15-2 Case report of a patient with two independent well-differentiated midgut neuroendocrine tumors(WDNT)-diagnostic doubts and treatment options

Efficacy and safety of ⁹⁰Y-DOTATATE therapy in neuroendocrine tumours

Efficacy and safety of 90Y-DOTATATE therapy in neuroendocrine tumours

Epidemiologia nowotworów neuroendokrynnych układu pokarmowego w Krakowie i powiecie krakowskim w latach 2007-2011

MON-584 Iodine Nutrition Status in Pregnancy: Is the Situation in Poland Improving?

Repeated cycles of peptide receptor radionuclide therapy (PRRT) – Results and side-effects of the radioisotope 90Y-DOTA TATE, 177Lu-DOTA TATE or 90Y/177Lu-DOTA TATE therapy in patients with disseminated NET

Repeated cycles of peptide receptor radionuclide therapy (PRRT) – Results and side-effects of the radioisotope90 Y-DOTA TATE,177 Lu-DOTA TATE or90 Y/177 Lu-DOTA TATE therapy in patients with disseminated NET

Aktive Filter

Suchergebnisse filtern